Histopathological biomarkers of immunotherapy outcome in advanced colorectal cancer: a multicentre retrospective study - Top-Institutions - MDSpire

Histopathological biomarkers of immunotherapy outcome in advanced colorectal cancer: a multicentre retrospective study

  • By

  • Jianying Chen

  • Yanzhi Chen

  • Zhigang Chen

  • July 6, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Shangrao People’s Hospital
    Shangrao People’s Hospital

    Shangrao, Jiangxi

    Key Differentiators

    • Oncology

  • #2

    University Hospital Cologne
    University Hospital Cologne

    Cologne, North Rhine-Westphalia

    Key Differentiators

    • Oncology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #4

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

Original Source(s)

Histopathological biomarkers of immunotherapy outcome in advanced colorectal cancer: a multicentre retrospective study

  • by Jianying Chen, Yanzhi Chen, Zhigang Chen

  • July 6, 2026

Related Content

Oncologic standards in colon cancer resection: from margins to lymph node yield and mesentery

Differential infiltration of CD4+ and CD8+ T cells and expression of PD-L1 in paired biopsy and resection specimens of gastric and colorectal adenocarcinomas

Postoperative anastomotic leakage after colon cancer surgery may reduce long-term survival